Otonomy Inc (OTIC.OQ)
OTIC.OQ on NASDAQ Stock Exchange Global Select Market
3.70USD
23 Apr 2018
3.70USD
23 Apr 2018
Change (% chg)
$-0.05 (-1.33%)
$-0.05 (-1.33%)
Prev Close
$3.75
$3.75
Open
$3.75
$3.75
Day's High
$3.92
$3.92
Day's Low
$3.70
$3.70
Volume
20,889
20,889
Avg. Vol
81,160
81,160
52-wk High
$21.15
$21.15
52-wk Low
$2.80
$2.80
Select another date:
Thu, Mar 8 2018
BRIEF-Otonomy Qtrly Loss Per Share $0.62
* OTONOMY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
BRIEF-Otonomy Announces FDA Approval Of Otiprio For Acute Otitis Externa
* OTONOMY ANNOUNCES FDA APPROVAL OF OTIPRIO(R) FOR ACUTE OTITIS EXTERNA
BRIEF-Otonomy Sees 2017 Non-Gaap Expenses Totaling $73-$78 Million
* OTONOMY INC - EXPECTS GAAP OPERATING EXPENSES FOR 2017 TO TOTAL IN RANGE OF $95-$100 MILLION
BRIEF-Otonomy Inc Immediately Discontinuing Commercial Support For Otiprio
* OTONOMY INC - IS IMMEDIATELY DISCONTINUING COMMERCIAL SUPPORT FOR OTIPRIO WHICH IS EXPECTED TO SIGNIFICANTLY REDUCE FUTURE OPERATING EXPENSES
BRIEF-Otonomy reports third quarter loss of $0.69 per share
* Otonomy reports third quarter 2017 financial results and provides corporate update
BRIEF-Otonomy reports positive results from averts-2 phase 3 trial of otividex™ in patients with ménière's disease
* Otonomy reports positive results from Averts-2 Phase 3 trial of Otividex™ in patients with Ménière's disease
Select another date:
- Otonomy (OTIC) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
- Otonomy's (OTIC) CEO David Weber on Q4 2017 Results - Earnings Call Transcript
- Biotech Forum Daily Digest For The Ides Of March
- PDUFA Watch List For March 2018 - Highlights For Amgen, Bristol-Myers, And Otonomy
- Biotech Forum Daily Digest For February 26th
- Otonomy (OTIC) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow